Skip to content

Rivastigmine

Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz (rivastigmine) is a small molecule pharmaceutical. Rivastigmine was first approved as Exelon on 1998-05-11. It is used to treat alzheimer disease in the USA. It has been approved in Europe to treat alzheimer disease, dementia, and parkinson disease. The pharmaceutical is active against acetylcholinesterase and cholinesterase.
Trade Name Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz
Common Name Rivastigmine
Indication alzheimer disease, dementia, parkinson disease
Drug Class Cholinesterase inhibitors (physostigmine type)
Rivastigmine
Get full access now